 | Up a level |
Frost, Nikolaj 
ORCID: 0000-0001-7452-7129, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jurgen, Gutz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian and Griesinger, Frank
(2021).
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
Ther. Adv. Med. Oncol., 13.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1758-8359
Saalfeld, Felix C., Wenzel, Carina ORCID: 0000-0001-5869-6934, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Merkelbach-Bruse, Sabine, Reissig, Timm M., Lassmann, Silke, Thiel, Sebastian, Stratmann, Jan A., Marienfeld, Ralf, Berger, Johannes, Desuki, Alexander, Velthaus, Janna-Lisa, Kauffmann-Guerrero, Diego, Stenzinger, Albrecht, Michels, Sebastian, Herold, Thomas, Kramer, Michael, Herold, Sylvia, Tufman, Amanda, Loges, Sonja ORCID: 0000-0002-7650-8527, Alt, Jurgen, Joosten, Maria, Schmidtke-Schrezenmeier, Gerlinde, Sebastian, Martin, Stephan-Falkenau, Susann, Waller, Cornelius F., Wiesweg, Marcel, Wolf, Juergen, Thomas, Michael, Aust, Daniela E. and Wermke, Martin
(2021).
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
J. Thorac. Oncol., 16 (11).
S. 1952 - 1959.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380